FUSN - Fusion Pharmaceuticals Inc.
IEX Last Trade
21.555
21.555 100.000%
Share volume: 0
Last Updated: Mon 03 Jun 2024 08:15:20 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-16 | 2023-05-11 | 2023-08-08 | 2023-11-07 | |
| Assets | ||||||||
| Total Assets | 235.960 M | 228.135 M | 238.493 M | 219.064 M | 266.551 M | 268.286 M | 253.377 M | |
| Current Assets | 204.777 M | 207.075 M | 215.846 M | 178.998 M | 220.624 M | 207.860 M | 203.265 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 7.211 M | 8.046 M | 9.721 M | 7.609 M | 10.272 M | 9.283 M | 11.407 M | |
| Short Term Investments | 7.211 M | 8.046 M | 9.721 M | 7.609 M | 10.272 M | 9.283 M | 11.407 M | |
| Total Receivables | 325.000 K | 177.000 K | 215.000 K | 61.000 K | 89.000 K | 62.000 K | 41.000 K | |
| Current Cash | 196.812 M | 198.423 M | 205.481 M | 170.874 M | 209.844 M | 198.096 M | 191.348 M | |
| Total Non-current Assets | 31.183 M | 21.060 M | 22.647 M | 40.066 M | 45.927 M | 60.426 M | 50.112 M | |
| Property Plant Equipment | 3.398 M | 3.506 M | 3.851 M | 4.631 M | 5.141 M | 5.709 M | 5.463 M | |
| Other Assets | 14.881 M | 14.299 M | 13.623 M | 13.850 M | 23.299 M | 19.449 M | 20.991 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 235.960 M | 228.135 M | 238.493 M | 219.064 M | 266.551 M | 268.286 M | 253.377 M | |
| Total liabilities | 20.534 M | 29.228 M | 55.351 M | 56.843 M | 65.718 M | 65.325 M | 64.906 M | |
| Total current liabilities | 12.182 M | 11.576 M | 13.412 M | 15.067 M | 17.325 M | 17.094 M | 17.478 M | |
| Accounts Payable | 1.774 M | 1.551 M | 1.311 M | 2.686 M | 1.904 M | 2.061 M | 1.057 M | |
| Other liabilities | 2.797 M | 2.797 M | 2.964 M | 2.966 M | 2.966 M | 2.966 M | 966.000 K | |
| Current long term debt | 1.434 M | 1.437 M | 1.431 M | 1.443 M | 4.638 M | 5.357 M | 6.166 M | |
| Long term debt | 5.555 M | 14.855 M | 38.975 M | 38.810 M | 45.427 M | 45.265 M | 46.462 M | |
| Other liabilities | 2.797 M | 2.797 M | 2.964 M | 2.966 M | 2.966 M | 2.966 M | 966.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 215.426 M | 198.907 M | 183.142 M | 162.221 M | 200.833 M | 202.961 M | 188.471 M | |
| Common stock | 43.170 M | 43.357 M | 43.684 M | 44.783 M | 53.776 M | 66.277 M | 69.050 M | |
| Retained earnings | -214.159 M | -233.232 M | -257.245 M | -281.862 M | -306.153 M | -331.328 M | -348.580 M |